Novel Au–SiO2–WO3 Core–Shell Composite Nanoparticles for Surface-Enhanced Raman Spectroscopy with Potential Application in Cancer Cell Imaging by Martínez Pancorbo, P et al.
FULL PAPER
www.afm-journal.de
1903549 (1 of 10) © 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Novel Au–SiO2–WO3 Core–Shell Composite Nanoparticles 
for Surface-Enhanced Raman Spectroscopy with Potential 
Application in Cancer Cell Imaging
Pablo Martinez Pancorbo, Kunyapat Thummavichai, Louise Clark, Tanveer A. Tabish, 
Jessica Mansfield, Ben Gardner, Hong Chang, Nick Stone, and Yanqiu Zhu*
With the rapid development of nanotechnology during the last decades, the 
ability to detect and control individual objects at the nanoscale has enabled 
us to deal with complex biomedical challenges. In cancer imaging, novel 
nanoparticles (NPs) offer promising potential to identify single cancer cells 
and precisely label larger areas of cancer tissues. Herein, a new class of size 
tunable core–shell composite (Au–SiO2–WO3) nanoparticles is reported. 
These nanoparticles display an easily improvable ≈103 surface-enhanced 
Raman scattering (SERS) enhancement factor with a double Au shell for dried 
samples over Si wafers and several orders of magnitude for liquid samples. 
WO3 core nanoparticles measuring 20–50 nm in diameter are sheathed by an 
intermediate 10–60 nm silica layer, produced by following the Stöber-based 
process and Turkevich method, followed by a 5–20 nm thick Au outer shell. By 
attaching 4-mercaptobenzoic acid (4-MBA) molecules as Raman reporters to 
the Au, high-resolution Raman maps that pinpoint the nanoparticles’ location 
are obtained. The preliminary results confirm their advantageous SERS prop-
erties for single-molecule detection, significant cell viability after 24 h and in 
vitro cell imaging using coherent anti-stokes Raman scattering. The long-term 
objective is to measure SERS nanoparticles in vivo using near-infrared light.
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the 2000s, positron emission tomog-
raphy (PET) combined with computed 
tomography (CT) was commercialized 
and started to be used worldwide due to 
its enhanced precision in the location of 
areas with highly active cells compared 
to older techniques. Its appearance had 
a great impact on cancer diagnosis until 
today, remaining the main technique for 
precise tumor location in the clinical stage 
for most types of cancers.[1] Unfortunately, 
this technique does not provide single cell 
detection and involves radioactive agents. 
More recent advances in optical imaging 
techniques such as deep Raman spectros-
copy-based approaches have enabled the 
potential to find single cancer cells inside 
of the human body without involving ion-
izing radiation. These novel techniques 
allow higher precision via light–molecule 
interactions by measuring biomarkers in 
the microscale, such as microcalcifications 
in breast cancer tissue.[2] More precise 
measurements using nanoscale objects 
labeled with Raman reporters could achieve single cell resolu-
tion for an optimal early stage cancer detection.[3]
In modern cancer imaging, the best personalized medical 
techniques are based on delivering nanoscale agents to cancer 
cells location while minimizing any undesirable interactions. 
However, many nanostructures do not arrive at the target 
and can induce toxicity. Hence, it is crucial to develop bio-
compatible nanoscale objects that contain clinically approved 
materials. Among many inorganic nanomaterials used, only 
iron-oxide (Fe3O4), silica (SiO2), and gold (Au) NPs are cur-
rently clinically accepted.[4] Iron oxide is used in imaging 
and thermal ablation of tumors; silica for fluorescent cancer 
imaging;[5] and gold for both surface-enhanced Raman spec-
troscopy (SERS) and photothermal ablation of tumors.[6] Plas-
monic nanoparticles (gold or silver) coated with Raman agents 
provide a platform for the emission of measurable Raman 
signals to optically locate the nanoparticles in the body, and 
therefore the cancer cells too.
The combination of different materials in the same particle 
to perform medical diagnosis and therapy in the same agent 
has become an important research topic, known as theranos-
tics. The most extensively studied composite nanoparticles 
SERS
1. Introduction
Cancer is the second main cause of death globally after car-
diovascular diseases, which are preventable via low-fat diet. 
Currently, the approach for cancer diagnosis is still based on 
nineteenth and twentieth century methodologies, which were 
supported in a limited knowledge of the cancer biology. In 
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in medical diagnosis are the colloidal ferromagnetic Fe3O4 
wrapped by functionalized Au core–shell NP for X-rays, SERS, 
and MRI imaging.[7] However, there are some important limi-
tations in all these applications. Medium to high energy X-rays 
can penetrate through the soft tissue in the human body but 
can induce new tumors and have poor contrast between soft 
tissues.[8] MRI uses Fe3O4 as a contrast agent due to favorable 
superparamagnetic properties, biodegradability, and easily 
modified surface properties for improved in vivo kinetics 
and multifunctionality.[9] Although MRI has a penetration 
depth only limited by the magnetic field, it has a low contrast 
between bound and unbound water molecules.[10] Further 
contrast is typically provided by injecting gadolinium-based 
enhancing agents. However, gadolinium has shown certain 
mechanisms for cytotoxicity.[11] The alternative, Fe3O4, is non-
cytotoxic but carries the risk of magnetic aggregation, forming 
very large particles that will not be excreted.[12] Au SERS uses 
nonionizing radiation that requires specific wavelengths in 
the near-infrared to penetrate the soft tissue, but penetration 
depth is typically up to only several centimeters.[13] However, it 
is one of the few techniques that allow achieving single cancer 
cell detection.
On the one hand, Au NPs have been extensively used as 
nanoprobes for SERS cancer imaging.[14] Their recent extension 
to Au nanoshells (Au NSs) covering in a core–shell structure 
has shown rather promising results for future biosensing,[15] 
by using specific molecules with benzene rings on top as the 
Raman reporters.[16] Spherical Au NPs have a range of surface 
plasmonic resonance wavelength excitations ranging from 
510 to 572 nm for particle sizes from 3 to 100 nm, and from 
520 to 932 nm excitations for Au NSs with different combina-
tions of internal diameters and external shell thickness, respec-
tively.[17,18] Apparently, thinner shells and larger internal diameters 
of nanoshells bring redshifts in the plasmonic generation.[18–20] 
Both Au NPs and Au NSs are well known for their good bio-
compatibility, ready bioconjugation,[21] and optical properties 
via plasmons.[22] On the other hand, Fe3O4 presents a behavior 
from superparamagnetic to ferromagnetic for 20 nm size 
or above of the nanoparticles which leads to significant mag-
netic nanoparticle aggregation.[23,24] Therefore, there is a drive 
to develop new materials that integrate alternative cores for 
Au nanoshells core–shell nanoparticles without magnetic 
aggregation.
Here we have explored the use of tungsten trioxide (WO3) 
that has excellent sensing properties,[25] including unique 
chromic behavior activated via thermal changes, electrical cur-
rents, and gases.[26] Additionally, some studies have previously 
shown potential oxygen vacancy induced ferromagnetism that 
brings magnetic hyperthermia capabilities,[27,28] and both bio-
compatibility and antibacterial properties.[29] Ultrasmall WO3-x 
nanodots have also been used recently for in vivo studies for 
multimodality imaging tumor imaging through computed 
tomography and photoacoustic imaging, and effective cancer 
treatment combining both photothermal therapy and radia-
tion therapy.[30] WO3 and WO2 transparency can be tuned by 
inducing a difference of electric potential or electric current, 
which can enhance or reduce the plasmonic generation of an 
external Au shell. However, Au and WO3 are not easily bound 
together, therefore an intermediate interface that helps to bind 
both the Au NPs and the WO3 core is needed. This interme-
diate layer needs to have low cytotoxicity for the human cells 
and should be able to accommodate the Au NPs easily. Porous 
silica (SiO2) NPs have previously been utilized to accommodate 
Au and have shown very low toxicity in the human body.[31] The 
synthetic steps are displayed in Figure S1 (Supporting Informa-
tion). To validate this design (Figure 1a), we will use the well-
established Raman reporter on Au, 4-mercaptobenzoic acid 
(4-MBA), to acquire the SERS signals. The schematic of the 
SERS process in the Au shell surface is explained in Figure 1b. 
It also shows that 785 and 830 nm are the two wavelengths 
used to obtain the Raman signals and maps, which are in the 
near-infrared region of the electromagnetic spectra. These 
wavelengths allow human tissue penetration while standard 
SERS that uses visible light would be fully absorbed by the 
organic tissues.
2. Results and Discussion
2.1. Characterization of Au–SiO2–WO3 Nanocomposites
Figure 2a displays the X-ray powder diffraction (XRD) patterns 
of the nanoparticles from each synthesis step. The peaks in 
each XRD pattern reveal the crystal structure of these mate-
rials. Along with the progression, the original monoclinic 
WO3 (Blue line) peaks are accompanied with lumps of the 
amorphous SiO2 at 23.1° (002), 23.6° (020), and 24.4° (200) 
(Black line), and then the cubic Au peaks appear (Red line) 
in the composite, benchmarked against the plain Au NPs at 
38.1° (111) and 44.3° (200) (Green line). The three main finger-
print peaks of monoclinic WO3 at 23.1°, 23.6°, and 24.4° are 
always present. This result confirms the bulk composite phase 
structures.
The phases identified by XRD are also verified by high-
resolution transmission electron microscopy (HRTEM) 
imaging. The lattice spacing is 0.265 nm (Figure 2b) for the 
monoclinic WO3 (020) core, and 0.235 nm for the Au (111) on 
top of the intermediate SiO2 shell (Figure 2b,c). Figure 2d–r 
shows the scanning transmission electron microscopy (STEM) 
images of the composite nanoparticles and their corresponding 
energy-dispersive X-ray spectroscopy (EDX) elemental mapping 
results. These maps reveal the detailed distribution features of 
each element at the nanoscale. Figure 2n–r represents the first 
step of the synthesis and shows that the core contains W and O, 
while the first shell being Si and O. This is consistent with the 
expected WO3 wrapped by SiO2. Figure 2i–m is the Au seeding 
step, in which Au in green color is found surrounding the 
SiO2 shell with a homogeneous distribution of small Au seeds. 
Figure 2d–h demonstrates the thick Au shell growth in green 
color as compared with that shown previously for the attached 
Au nanoseeds. Finally, the STEM-EDX and HRTEM results 
both confirm an average diameter of 3.5 ± 1.0 nm for the par-
ticulate Au nanoseeds.
The WO3 core used in this material is polydispersed and 
add a big uncertainty in the final shape and size, especially for 
thin layers of SiO2 and Au. Also, the purity of the source can 
Adv. Funct. Mater. 2019, 1903549
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be refined to avoid crosslinked WO2 contamination or use WO2 
cores directly during the synthesis, which has smaller energy 
bandgap for displaying electrochromic behavior. The reduction 
of the final overall size can help to improve excretion rates of 
the nanoparticles after imaging.[32–35]
2.2. Control of SiO2 Shell Thickness
Figure 3 shows the SiO2 thickness dependency on the ratio 
of ammonia:TEOS. To achieve thickness control, the volume 
of ammonia remains constant at 1 mL for all the displayed 
coatings in Figure 3. This follows the principles of the Stöber 
process that describes the growth of SiO2 NPs.[36] When the 
amount of TEOS increases over the ammonia, the coating is 
thicker, and vice versa (Figure 3a–f). This has been previously 
addressed using different cores by several authors.[37–39] The 
thickness of the SiO2 can be minimized down to 3 nm. How-
ever, the relationship between the thickness and the concentra-
tion of TEOS is nonlinear. On the other hand, the current core 
has been found to exhibit some potential cytotoxicity for certain 
cells,[40–42] so it needs to be wrapped thick enough to ensure it 
never directly interacts with healthy cells. TEOS is the main 
parameter determining the SiO2 layer thickness.
2.3. Attachment of Au NPs
There are several very important optical and chemical properties 
of Au NPs that depend strictly on the type of ligand and ligand-
metal bond. 3-Aminopropyltrimethoxysilane (APTS) is one of 
the most common chemicals used to amine-functionalized 
surfaces for successive Au attachment due to its stable bonding 
with Au, fast attachment, and low cost.
Figure 4a displays the sample prepared with 4 times fewer 
APTS concentration than the one used to prepare the sample 
shown in Figure 4b during the amine functionalization pro-
cess. Figure 4 shows that an increment of the APTS content 
leads to a more homogeneous Au seeding over the SiO2 sur-
face. The concentration of APTS used in this study produced 
Au NPs of 3.5 nm ± 1.0 nm in diameter.
2.4. Plasmonic Light Absorption
Figure 5a shows the ultraviolet–visible (UV–vis) absorption 
spectra of various synthesis stages, which reveals the plasmon 
excitation wavelengths and the maximum absorption peak 
of Au, and the visible color displayed by the colloidal. The 
plain Au colloidal appears as red, with maximum absorption 
Adv. Funct. Mater. 2019, 1903549
Figure 1. a,b) Schematic of the composite NP design and SERS effect over the gold nanoshell, respectively. c) Colloidal nanoparticles solutions made 
of Au, SiO2–WO3, and Au–SiO2–WO3 covered with Au seeds and Au shells within thick layers, respectively. d) Au–SiO2–WO3 nanoparticles solutions 
with various Au thickness obtained by using different Au stock solution during the shell formation.
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at 510 nm; whilst the colloidal of nanoshell version of Au–
SiO2–WO3 appears purple with an absorption peak at 532 nm.[43] 
Figure 5b, which corresponds to the colloidal nanoparticles dis-
played in Figure 1d, displays the evolution of the absorption 
spectra during the nanoshell formation in which X represents 
the volume of 25 × 10−3 m Au stock solution as explained in the 
methods section. Also, there is a clear redshift when the aggrega-
tion of the Au and Au–SiO2–WO3 NPs takes place. The optimal 
scenario is a maximum peak in the near-infrared regime to have 
the highest plasmonic oscillations for the SERS application with 
near-infrared laser illumination. There are no local maximum 
peaks for the nonmetallic materials, as expected since they do 
not have plasmon resonances. Also, the contribution of SiO2 is 
negligible but starts to be relevant for increased wavelengths.
2.5. SERS Maps with 4-MBA Reporter
Figure 6a–c shows the Raman spectra of 4-MBA molecules 
bound to the shelled Au–SiO2–WO3, seeded Au–SiO2–WO3 and 
Adv. Funct. Mater. 2019, 1903549
Figure 2. Characterization of the nanocomposites. a) XRD profiles of the WO3, SiO2–WO3, Au–SiO2–WO3 and Au. b) HRTEM images of WO3 and c) Au. 
d–h) STEM-EDX element mapping of Au nanoshell on Au–SiO2–WO3: STEM image, RGB overall, W, Au, and Si, respectively. i–m) STEM-EDX element 
mapping of Au nanoseeds on Au–SiO2–WO3: STEM image, RGB overall, W, Au, and Si, respectively. n–r) STEM-EDX element mapping of SiO2–WO3: 
STEM image, RGB overall, W, O, and Si, respectively.
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4-MBA alone, respectively. The substrate that holds the sam-
ples is a Si wafer and acts as a reference to control the intensity 
performance of the vibrational resonance peaks from the fixed 
concentration and volume of 4-MBA molecules, and therefore, 
the SERS effect quality. It is clear from Figure 6a–c that for Au 
content there is a boost in these peaks against the 4-MBA mole-
cule alone in Figure 6c.[44] The maximum enhancement of 771 
times over the original signal is achieved for the core–shell NPs 
nanoshelled with Au twice as shown in Figure S2b (Supporting 
Information). This factor is more than four times achieved 
value with the 3.5 nm Au nanoseeds on the SiO2 surface from 
Figure 6b. This implies that for higher resolution and detection 
power, the complete nanoshell is essential. All the enhance-
ment factor calculations have been carried out using the same 
Raman reporter molecule concentrations. A quick compar-
ison with previous results using bare Au nanoparticles for the 
same overall size shows that these composite nano particles 
achieved lower enhancement factors, mainly due to the bluer 
maximum absorption peak position.[45,46] Smaller monodis-
persed cores and thinner silica shells can be the key for a sub-
stantial improvement to match the surface plasmon resonance 
wavelength. Larger enhancements can be easily achieved by 
increasing the gold nanoshell thickness while keeping non-
smooth surfaces. It can also be improved with the addition of 
another external Au layer on top of the Raman molecules to 
create hot spots.
4-MBA is a thiol that contains a benzene ring in the R part, 
which forms the aromatic ring. This ring provides a strong 
Raman scattering cross-section with characteristics peaks 
of 1078 cm−1 and 1589 cm−1 (see Figure 6). We chose this 
mole cule due to its features of stable sulfur bond with Au, 
easy attachment, and pH sensitivity in the Raman spectra.[47] 
Adv. Funct. Mater. 2019, 1903549
Figure 3. TEM images of SiO2–WO3 samples with different ratios of ammonia:TEOS. a) 4:1, b) 6:1, c) 8:1, d) 10:1, e) 20:1, and f) 50:1.
Figure 4. TEM images of Au nanoseeds attachment. Au–SiO2–WO3 NPs synthesized with different APTS additions: a) 50 µL. b) 200 µL.
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Depending on the intensity and position of the peaks, dif-
ferent thiolated reporter molecules can be investigated to find 
the most suitable Raman reporters for potential use when 
labeling specific cell types such as cancer cells. The nano-
particles synthesized in this paper achieve easily improvable 
10 and 103 SERS EFs for one Au shell and double Au shell, 
respectively, in dried samples over Si wafers (see Figure 6a 
and Figure S2b, Supporting Information). Also, several orders 
of magnitude were found for the double Au layer for liquid 
samples (see Figure S2a, Supporting Information), which is 
very promising for future in vivo applications due to including 
optical absorption similar to organic human soft tissue. All 
these values were obtained by diving the SERS signal by the 
background silicon peak to normalize them and subsequently 
measuring the ratio of the SERS peak versus the molecule 
without plasmonic enhancement. Moreover, we have not dis-
played the Raman enhancement from the Au seeds without 
attaching to the silica shell because the intensity of the 4-MBA 
peaks was as strong as the molecules alone for both near-
infrared lasers.
Principal component analysis (PCA) is an adaptive data 
analysis technique that combines conventional imaging 
and spectroscopy to simultaneously obtain both spatial and 
spectral information from an object by reducing a large set 
of possibly correlated variables to a small set of uncorrelated 
variables, called principal components that still contains 
most of the relevant information from the large set.[48,49] The 
origin of the new coordinate system is located in the center 
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Figure 6. a–c) SERS spectra of 4-MBA molecule peaks at 1078 and 1589 cm−1 with 830 nm laser and d–f) Raman maps with 785 and 830 nm of 
different samples with 4-MBA Raman reporter over a silicon wafer with its characteristic reference peak at 520 cm−1. a) Au shelled Au–SiO2–WO3. 
b) Au seeded Au–SiO2–WO3. c) Plain 4-MBA molecules. d–f) Optical microscopy image, Raman maps under PC1 (66.09%) taken with 785 nm and 
830 nm lasers, respectively.
Figure 5. UV–vis absorption spectra of various colloidal nanoparticles: a) WO3, SiO2–WO3, Au seeded Au–SiO2–WO3, Au shelled Au–SiO2–WO3 (and 
aggregated batch, after 2 weeks stored in room temperature) and Au alone (and aggregated batch, after 2 weeks stored in room temperature). b) Au–
SiO2–WO3 shelled with different Au stock solution (X) used during the shell formation.
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of the data points, the first PCA step includes the points in 
the direction of the highest variance, the second PCA step 
includes the ones for the second-highest variance and the 
rest follow this trend. Using the first PCA, which describes 
the greatest variance in the dataset (66.09%) in the Raman 
maps, we can find where the 4-MBA molecules are located: 
dark red means 4-MBA and dark blue represents the Si wafer 
(Figure 6e,f). This information is not obvious from the optical 
image (Figure 6d); however, the Raman maps are able to 
identify the locations of these reporters. The SERS intensity 
of the aggregated areas is not only due to the 2D spatial dis-
tribution of the materials but also due to having several layers 
that lead to stronger hot spots[50] and cannot be seen with the 
optical microscope. After subsequent attachment of the nano-
particles to or uptake into cancer cells, the cancer cells will be 
precisely located.
Targeting and localization of cancer cells can be achieved by 
functionalizing the Au nanoshell with cancer ligands such as 
antibodies, which are customized for each type of cancer. One 
type of promising ligand is the anti-HER monoclonal anti-
bodies for the treatment of various types of cancers including 
HER-2+ metastatic breast, colorectal, NSCLC, pancreatic, 
breast, HNSCC, ovarian and renal tumors.[51,52] Should these 
core–shell nanoparticles provide sufficient signals in combi-
nation with bright Raman reporters in the near-infrared, the 
SERS signals could be readout using microscopy in individual 
cancer cells. Moreover, they also could visualize in vivo tissues 
with Raman fiber probes or surface-enhanced spatially offset 
Raman spectroscopy (SESORS).
2.6. Cytotoxicity Profile in a Triple-Negative Human Breast 
Cancer Cell Line MDA-MB 231
Figure 7a shows the in vitro cytotoxicity profile of the selected 
concentrations (100, 250, 500, and 1000 µg mL−1) of four dif-
ferent batches (A1, A2, B1, B2) of Au–SiO2–WO3 nanoparticles 
in a triple-negative human breast cancer cell line MDA-MB 231. 
A1, A2, B1, B2 represent single layer of Au, single layer of Au 
coated with 4MBA, double layer of Au and double layer of Au 
coated with 4MBA, respectively. The NPs concentration range 
was selected from the minimum concentration showing low 
toxicity to concentration showing maximum toxicity. A live–
dead assay for a period of 24 h was performed to confirm the 
suitability of the nanoparticles for biomedical applications. Sta-
tistical analysis was performed with three batches per sample 
and concentration of which the mean and standard deviation 
were calculated. The results show no statistical significance (ns, 
p ≥ 0.05) for concentrations 500 µg mL−1, while for concentra-
tions of 100, 250, and 1000 µg mL−1 the results are statistically 
significant (*, p < 0.01 to 0.05) as shown in Figure 7a. Among 
the statistically significant results, low cytotoxicity (>75% alive 
cells) after 24 h was found for concentrations of 100 µg mL−1 
indicating their suitability for cell imaging purposes.
2.7. Cell Imaging in Human MDA-MB 231 Breast Cancer Cells
The cancer cells were visualized by imaging the CARS signal 
generated from the CH molecular vibrations within the 
Adv. Funct. Mater. 2019, 1903549
Figure 7. a) Cytotoxicity tests after 24 h of samples A1 (single layer of Au), A2 (single layer of Au coated with 4MBA), B1 (double layer of Au) and 
B2 (double layer of Au coated with 4MBA). The values represent the mean ± standard deviation of three experiments; * denotes p < 0.05 (statistical 
significance) and ns represents p ≥ 0.05 (nonstatistical significance). b) Average values and standard deviations errors from CARS spectra from cells 
alone and cells with nanoparticles. c) Control cells CARS stack—z-projection image in grayscale. d) CARS 3D demonstration of nanoparticles B1 within 
the cell in grayscale and e) its z-projection of the entire stack (recolored intensity-dependent with fire LUT in ImageJ). f) Nanoparticles A2 in cells 
CARS imaging (recolored intensity-dependent with fire LUT in ImageJ). g) z-stacking of CARS images from cells and nanoparticles stack A1 (recolored 
intensity-dependent with fire LUT in ImageJ).
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cells, this signal was chemically specific with a peak around 
2940 cm−1. The nanoparticles within the cells also exhibited a 
very strong signal within the CARS channel, however, this was 
from a four-wave mixing process, which was not chemically spe-
cific. Figure 7b compares the spectra of the cells to the spectral 
of the Au–SiO2–WO3 NPs within the cells. The average value 
and standard deviation of three measurements were taken and 
plotted for both the cells only and the cells with the NPs. The 
intensity of the signal in cells with NPs is a few times higher 
than cells alone, which indicates high sensitivity to locate the 
NPs. Figure 7c–g shows the cell imaging results obtained with 
CARS. The control label-free human MDA-MB 231 breast 
cancer cells without nanoparticles are shown in Figure 7c, this 
image is a z-projection of a CARS image stack and the contrast 
is from the CH vibrations within the cells. Then, in Figure 7d, 
CARS 3D cross-sections of NPs with a double layer of Au 
(white color) within the cells (gray color) in gray confirms that 
the nanoparticles were uptaken by the cells and can be seen 
from the inside of the cells. Additionally, the z-projection of the 
entire stack of CARS images was implemented in Figure 7e 
by applying the color filter fire look-up-tables (LUT) in ImageJ 
over the original intensity-dependent greyscale. This recolored 
image shows the nanoparticles (white) located inside the cells 
(purple) at different z-positions. Similarly, Figure 7f,d shows 
the z-projection of the entire stack with fire LUT recoloration 
for nanoparticles with a single layer of Au coated with 4MBA 
and without 4MBA, respectively. These results along with the 
cytotoxicity profiles confirm the viability for these nanoparticles 
to be used in cancer cell imaging.
3. Conclusion
In summary, we have demonstrated a size tunable synthesis 
method to obtain novel Au–SiO2–WO3 NPs. Higher APTS con-
centrations result in attachment of larger numbers of seeding 
Au NPs over the SiO2 layer. Along with the synthesis, modifica-
tions in the intensity of the ultrasonication and speed in the 
centrifugation can be introduced to refine the washing process 
and avoid nanoparticles agglomerations. On the one hand, by 
repeating the Au shell growth step, several gold shells are cre-
ated and stronger SERS is achieved as displayed in Figure S2a 
(Supporting Information). This ability to increase the enhance-
ment factor is crucial for translational biomedical applications 
that involve media that attenuates the near-infrared laser inten-
sity. On the other hand, the main parameter for the SiO2 thick-
ness growth is the ratio between TEOS and ammonia. Higher 
ratios of ammonia:TEOS lead to thinner SiO2 thickness, which 
reduces the potential toxicity in the human body through a 
faster excretion. However, it could increase the risk of dis-
playing cytotoxicity related to partially uncoated WO3 cores. The 
final Au–SiO2–WO3 NPs have been systematically obtained in 
more than 10 batches by following the synthetic procedure, this 
reflects the high reproducibility of the synthesis. The optimal 
thickness of the SiO2 and Au nanoshells for both strong SERS 
and low toxicity has yet to be determined. However, preliminary 
results from various configurations show highly reproducible 
accurate nanoparticles detection in 2D human breast cancer 
cell culture and liquid media which leads to believe in vivo cell 
imaging can be achieved. Moreover, cytotoxicity tests after 24 h 
show >75% alive cells from statistically significant cell viability 
at concentrations of 100 µg mL−1. This is a very promising 
translational result that encourages the use of these nanoparti-
cles in future live human cancer cells imaging and 3D human 
cell culture models such as spheroids, organoids and organ-on-
a-chip technologies to have the full picture of how beneficial 
these nanoparticles can be in the clinical stage.
4. Experimental Section
Materials: All the following reagents were purchased from Sigma-
Aldrich: gold(III) chloride hydrate (HAuCl4.xH2O, 99.999% trace metals 
basis MW 339.79 g mol−1), tetrakis (hydroxymethyl)phosphonium 
chloride solution (THPC, 80% in H2O), (3-aminopropyl)triethoxysilane 
(APTS), potassium carbonate (K2CO3, 99.995% trace metals basis 
MW 138.21 g mol−1), sodium hydroxide (NaOH, Sigma-Aldrich), 
potassium carbonate (K2CO3), formaldehyde (CH2O (HCHO)), 
4-mercaptobenzoic acid (MBA), deionized water, ethanol, formaldehyde 
solution, Dulbecco’s modified Eagle’s medium (DMEM), trypsin–EDTA 
solution, and cell proliferation reagent WST-1. The WO3 nanoparticles 
were purchased from China, Chang Sha Na Ro Mei Nanomaterials 
Ltd, with a purity of 99.9% and an average size of 40 nm. Culture cell 
serum-supplement and penicillin–streptomycin were purchased from 
Gibco.
Cell Culture: The MDA-MB 231 human breast cancer cells were 
cultured in DMEM with 10% serum-supplement and 1% penicillin–
streptomycin. Cells were grown under standard conditions of 5% 
CO2 and 37 °C in a controlled humidified incubator to reach 70–80% 
confluence. Cells were routinely subcultured using 0.25% trypsin–EDTA 
solution.
Characterization Instruments and Conditions: The nanoparticles were 
characterized by using the Thermo Scientific Evolution Array UV–vis 
spectrophotometer to obtain the light absorption spectra of the colloidal 
composite nanoparticles suspended in ethanol at mild conditions. For 
the electron microscopy images and the EDX element maps, the JEOL 
2100 TEM/STEM system was used. The XRD patterns were obtained with 
the Bruker D8 advanced XRD machine working at 0.03° step per second 
of 2θ from 10° to 80° at room temperature. Raman signals, maps, and 
optical images for dried samples were obtained from samples dried on 
top of silicon wafers by using 785 and 830 nm lasers integrated into the 
Renishaw Invia Raman system and with its internal optical microscope 
at standard room conditions.
Silica Nanoshell Formation: The first step was the synthesis of 
the SiO2–WO3 core–shell nanocomposites (Figure S1, Supporting 
Information), NP following the Stober process. A liquid suspension made 
of 10 mL deionized (DI) water, 20 mL ethanol, and 0.015 g WO3 NPs was 
first prepared, then a modified Stöber process promoted the formation 
of the SiO2 shell via the sol–gel method. In this method, consecutive 
hydrolysis and condensation of alkoxysilanes in an aqueous-alcoholic 
solution in the presence of a base catalyst were involved, using tetraethyl 
orthosilicate (TEOS) as alkoxysilane and ammonia as the base catalyst.
In this paper, a different route from other Stöber-based versions was 
taken to perform the silica synthesis while in parallel coating the core. 
WO3 NPs were coated with SiO2 by adding 1 mL ammonia and 5 drops 
of TEOS while stirring the WO3 suspension with a time interval of 10 s 
between each TEOS drop. This was the key to create the SiO2 coating 
because by changing the concentration of TEOS the SiO2 thickness could 
be modified. After that, the mixture was stirred continuously for 30 more 
min. The ammonia concentration catalyzed this reaction by increasing 
the reaction rate. Finally, the suspension was washed with deionized 
water and Ethanol by centrifugation to separate the nanoparticles from 
the liquid in 50 mL Eppendorf tubes.
Amine Functionalization: The SiO2–WO3 core–shell nanocomposite 
surfaces were functionalized with an amine group. First, 0.015 g 
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SiO2–WO3 core–shell nanocomposites (Figure S1, Supporting 
Information) was dispersed in 20 mL of ethanol in a beaker and 
subjected to 30 min ultrasonic probe treatment. Then, 500 µL of 
APTS was added to the suspension, which was heated to 70 °C under 
the magnetic stirring for 5 h. To remove the excess reactants, the 
suspension of 25 mL ethanol was centrifuged for three times (10 min 
per cycle at 6 000 rpm) without washing and redispersed by ultrasonic 
probe treatment.
The key aspect of this functionalization was the NH2 ending on 
top.[53] These NH2 ligands reacted with Au after breaking it in two parts 
by heating. On the one hand, H2 was released on one side when the H 
atoms absorbed higher energy than the bond. On the other hand, a very 
strong bond was created between the N and the Au atoms that were 
close enough to be attracted by the electric force of the N2− ions and the 
Au electron cloud. This fact made it possible to attach Au nanoseeds and 
to stable subsequent Au growth on top with homogeneous distribution.
Colloidal Au–SiO2–WO3 NPs Fabrication: Colloidal Au NPs can be 
obtained following different methods, which are based on the work of 
Turkevich et al.[54] Herein they were NP obtained by reducing Au salts 
(HAuCl4) in the presence of surfactants, tetrakis (hydroxymethyl) 
phosphonium chloride (THPC, C4H12ClO4P).[55] During the formation of 
the metallic solution, a huge excess of NaOH was formed. The reactions 
between THPC and NaOH produced formaldehyde as the reducing 
agent for Au. After the amine functionalization, the gold coating process 
is implemented.
By dissolving 0.098 g of HAuCl4·3H2O in 10 mL of deionized water,a 
25.0 × 10−3 m Au stock solution was prepared, called chloroauric acid. By 
typical reducing the chloroauric acid with THPC, the colloidal Au NPs 
(13 × 10−9 m) was prepared. In detail, 3 mL of 1 m NaOH (0.2 g in 5 mL 
deionized water) and 1 mL of diluted THPC (12 µL of 80% THPC per 
1 mL of deionized water, 50 × 10−3 m) were added to 44 mL of deionized 
water while being stirred. The solution was magnetically stirred for 5 min 
and 2 mL of the 25 × 10−3 m Au stock solution was rapidly added in and 
the color quickly changed to dark red or brown. The final Au colloidal was 
stored at 5 °C for 12 h, prior to being used for later Au coating process.
5 mL of the amine-functionalized SiO2 core–shell nanocomposites 
suspension of 70 °C was added to 20 mL of magnetically stirred Au 
colloidal NP of 100 °C, and then continuously stirred for 10 min. The 
resulting colloidal suspension NP was washed with deionized water 
under centrifugation for three times at 6000 rpm for 10 min each time, 
to remove the excess of reactants.
Au Shell Synthesis: Once the Au nanoseeds were attached to the SiO2 
nanoshell, the Au started to grow to form the final out layer.[56] The 
alkaline growth solution was prepared by dissolving 0.025 g potassium 
carbonate (K2CO3) in 100 mL deionized water (0.18 × 10−3 m). Then 
1.5 mL of 25 × 10−3 m (1% w/v) of the Au stock solution was added to 
the growth solution, and the mixture was stirred until the yellow colloidal 
suspension became clear (transparent). 20 mL of this clear solution was 
injected with 1 mL of the Au–SiO2–WO3 NPs suspension, then 100 µL 
of formaldehyde was added, and a color change from colorless to purple 
was observed which is characteristic of the Au nanoshell formation. 
The resultant suspension was then centrifuged and redispersed in 
water, for later UV–vis spectrophotometry and Raman spectroscopy 
characterization.
Adding Reporter Molecule for SERS: The Au nanoshell bioconjugation 
was achieved by mixing 4-mercaptobenzoic acid (4-MBA) diluted 
in ethanol with the Au–SiO2–WO3 nanocomposites.[57] After these 
synthesis steps, thiolated Au–SiO2–WO3 core–shell nanocomposites 
were obtained. Figure S1 (Supporting Information) describes the entire 
synthesis steps. 1 × 10−3 m of 4-MBA solution was prepared by diluting 
an appropriate mass of the solid in ethanol (or aqueous). For the 
collection of SERS spectra, 100 µL of 1 × 10−3 m solution of 4-MBA was 
mixed with 1 mL of colloidal Au NPs. After 5 min stirring, the mixture 
was centrifuged three times for 7 min at 4000 rpm in 1.5 mL Eppendorf 
tubes, and the supernatant was redissolved in deionized water.
Cell Viability: Cell viability experiments were performed in 96-well 
plates and imaging experiments were performed in six-well plate. Cells 
were seeded in a 96-well plate at the density of 1 × 104 cells per well 
while cells were seeded onto the six-well plates at a density of 1 × 106 
cells per well and incubated for 24 h prior to the experiments. After 
overnight incubation, cells were treated with and without 100, 250, 
500, and 1000 µg mL−1 of four types of NPs for 24 h. Cell viability after 
nanoparticle treatment was determined using WST-1 assay (Roche 
Applied Biosystems) according to the manufacturer’s instructions 
with modifications to adapt for nanoparticle-treated cells. Briefly, cells 
were seeded in a 96-well plate with a density of 1 × 104 cells per well, 
differentiated and incubated with nanoparticles (three replicates per 
concentration). After 24 h, WST-1 reagent was added to the cells, and 
after the color reaction, the plate was then kept for shaking and then 
absorbance was measured at a wavelength of 450 nm using a plate reader 
(Clariostar plate reader, BMG labtech). The results were expressed as 
percentage cell viability. Three independent experiments were performed 
for each study and all measurements were performed in triplicate.
Statistical Analysis: The data were statistically analyzed using 
GraphPad Prism 5.04 to assess the effects of NPs treatment on cell 
viability and were expressed as % cell count ± SD, Mann Whitney. 
*(p < 0.05) was considered statistically significant. Results were 
presented as the mean ± standard deviation (SD).
Cell Imaging Using Coherent Antistokes Raman Spectroscopy: Coherent 
anti-Stokes Raman scattering (CARS) imaging was carried by using 
dual-wavelength output from an InSight X3 ultrafast fs laser (Newport 
SpectraPhysics) with 800 nm for the pump and probe beam and 1045 nm 
as the Stokes beam. The beams where chirped to produced ps pulses 
and spatially overlaid in the Spectral Focusing Timing and Recombination 
Unit (SF-TRU, Newport SpectraPhysics). The temporal overlap between 
the pump and Stokes beams was scanned via the SF-TRU unit to allowing 
us to rapidly change which Raman vibration was probed, and acquire 
spectral data.[58] 3D submicron resolution imaging was performed on 
a modified confocal microscope (Olympus FV3000), with a 60× water-
immersion objective (1.2NA, UPlanSApo, Olympus). The anti-Stokes light 
at 648 nm from CARS was collected in the forward direction using a water 
immersion objective (Olympus LUMPlanFLN 60X). The anti-Stokes light 
was separated from the laser fundamentals by using a long pass dichroic 
beamsplitter (Chroma DC/T760lpxr) followed by two filters (Chroma 
ET650/45x) and detected using a PMT (Hamamatsu R3896). The 
samples were mounted between two coverslips. To avoid photodamage 
to the samples, the laser intensities were attenuated to give 9 and 18 mW 
for the pump and Stokes beams in the sample plane, respectively.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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